Insider Transactions in Q2 2024 at Ideaya Biosciences, Inc. (IDYA)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2024
|
Jason Throne Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
53,484
+35.34%
|
$534,840
$10.18 P/Share
|
|
May 29
2024
|
Michael Anthony White Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
28,500
-98.51%
|
$1,026,000
$36.5 P/Share
|
|
May 29
2024
|
Michael Anthony White Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,500
+50.0%
|
$342,000
$12.86 P/Share
|
|
May 16
2024
|
Yujiro S Hata President and CEO |
SELL
Open market or private sale
|
Direct |
34,433
-2.43%
|
$1,446,186
$42.05 P/Share
|
|
May 16
2024
|
Yujiro S Hata President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
34,433
+4.61%
|
$137,732
$4.31 P/Share
|
|
May 15
2024
|
Yujiro S Hata President and CEO |
SELL
Open market or private sale
|
Direct |
83,856
-3.77%
|
$3,605,808
$43.39 P/Share
|
|
May 15
2024
|
Yujiro S Hata President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
83,856
+9.92%
|
$335,424
$4.31 P/Share
|
|
May 14
2024
|
Yujiro S Hata President and CEO |
SELL
Open market or private sale
|
Direct |
56,711
-3.87%
|
$2,325,151
$41.72 P/Share
|
|
May 14
2024
|
Yujiro S Hata President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
56,711
+7.17%
|
$226,844
$4.31 P/Share
|